醫(yī)學(xué)免疫學(xué)-免疫耐受(英文)_第1頁
醫(yī)學(xué)免疫學(xué)-免疫耐受(英文)_第2頁
醫(yī)學(xué)免疫學(xué)-免疫耐受(英文)_第3頁
醫(yī)學(xué)免疫學(xué)-免疫耐受(英文)_第4頁
醫(yī)學(xué)免疫學(xué)-免疫耐受(英文)_第5頁
已閱讀5頁,還剩39頁未讀, 繼續(xù)免費(fèi)閱讀

下載本文檔

版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請進(jìn)行舉報(bào)或認(rèn)領(lǐng)

文檔簡介

Immunologicaltolerance

1IntroductionEstablishmentofimmunologicaltoleranceMechanismsofimmunologicaltoleranceSignificanceandclinicalapplicationContents

2IntroductionEstablishmentofimmunologicaltoleranceMechanismsofimmunologicaltoleranceSignificanceandclinicalapplicationContents

3IntroductionAgT/Bactivated—EffectorcellAstateofunresponsivenessSpecificforaparticularantigenTolerogen:4IntroductionToleranceResponse“Yin”and“Yang”homeostasisThemostimportantaspect——selftolerancepreventsthebodyfrommountinganimmuneattackagainstitsowntissues5IntroductionClinicalSignificanceautoimmunediseasestumortransplantationinfection61945:Owen“Experimentofnature”innon-identicalcattletwinsIntroduction-Historicalbackground71949:Burnet&FennerIfinembryoniclifeexpendablecellsfromageneticallydistinctraceareimplantedandestablished,noantibodyresponseshoulddevelopagainsttheforeigncellantigenwhentheanimaltakesonindependentexistence.Introduction-Historicalbackground81953:PeterMedawarNewBornFetusAdultStageAdultStageIntroduction-HistoricalbackgroundGraftrejectionGraftrejectionGraftsurvivalAstrainAstrainAstrain91957:Burnet’sclonalselectiontheorySelf-AgForeignAgSelf-AgProgenitorcellsLymphocyteswithspecificdifferentBCR/TCRduringembryostageEliminationofimmatureself-reactivelymphocyteclonesbyclonaldeletionMatureandna?velymphocyterepertoireAntigenspecificlymphocytecloneexpansion(effectcell)andantigeneliminationIntroduction-Historicalbackground10FrankMacfarlaneBurnetandPeterBrianMedawar

"for

discoveryofacquiredimmunologicaltolerance"Introduction-Historicalbackground11TypesofimmunologicaltoleranceIntroduction-TwotypesoftoleranceCentraltoleranceLymphocytespassthroughastageinwhichtheyencounterself-Agleadingtotoleranceratherthanactivationduringtheirmaturationinthecentrallymphoidorgans.PeripheraltoleranceItisinducedbyrecognitionofantigensduetoinadequatelevelsofthecostimulatorsthatarerequiredforlymphocyteactivation,orbypersistentandrepeatedstimulationbyself-Aginperipheraltissues.12IntroductionEstablishmentofimmunologicaltoleranceMechanismsofimmunologicaltoleranceSignificanceandclinicalapplicationContents

13Establishmentofimmunologicaltolerance(1)Antigen-associatedfactorsLow-zonetoleranceAgoftoolowdosagedoesnotinitiateimmuneresponse.High-zonetoleranceAgofhighdosagedoesnotinitiateimmuneresponse.DOSE?14DifferentfeaturesofT

andB

celltolerance T BToleranceinduction

easy

difficultDoseofAg

low

highPersistenttimelonger

shorterEstablishmentofimmunologicaltolerance(1)Antigen-associatedfactors15DaysafterAgimmunizationImmunologicaltoleranceTcellSpleenBcellsBonemarrowBcellsTheminimumtolerancedose:Bcells,1-10mg;Tcells,10ug16MonomerPhysicalnatureEstablishmentofimmunologicaltoleranceAbAbpolymerTolerance(1)Antigen-associatedfactors17RouteofAdministrationEstablishmentofimmunologicaltolerance(1)Antigen-associatedfactorsOraladministrationmucosalimmunityinlocalsystemictolerance18RouteofAdministrationEstablishmentofimmunologicaltolerance(1)Antigen-associatedfactorsOralIntravenousIntra-peritonealIntramuscularsubcutaneousImmuneresponseTolerance19EstablishmentofimmunologicaltolerancePersistenceofAgAntigenicvariationHIV,HCVstimulatesTcellsapoptosis(1)Antigen-associatedfactors20EstablishmentofimmunologicaltoleranceFactorsaffectingtolerance

roleofantigenFactors

thataffect

response

FavorImmuneresponse

FavorTolerance

Physical

form

of

Ag

Route

of

injection

Dose

of

antigen

Large,

aggregated,complex

molecules,properly

processed

Subcutaneousorintramuscular

Optimal

dose

soluble,aggregate-free,simple

small

molecules,not

processed

Oral

or,sometimes,intravenous

Very

large

or

very

small

dose

21EstablishmentofimmunologicaltoleranceSpeciesStatusofimmunesystemEasyinmurineandratDifficultinhuman(2)Host-associatedfactorsAgePhysicalstatusGeneticbackground22EstablishmentofimmunologicaltoleranceFactorsaffectingtolerance

roleofhostFactors

thataffect

response

FavorImmuneresponse

FavorTolerance

Ageofrespondinganimal

Differentiationstateofcells

Fullydifferentiated;memoryT&Bcells

Older,immunologicallymature

Newborn(mice),immunologicallyimmature

RelativeundifferentiatedBcellwithonlyIgM,Tcellsinthethymiccortex

23IntroductionEstablishmentofimmunologicaltoleranceMechanismsofimmunologicaltoleranceSignificanceandclinicalapplicationContents

24Mechanismsofimmunologicaltolerance(1)CentralTolerance(incomplete)NegativeselectionofT,BcellsincentralimmuneorgansSelf-T、BSelf-AgClonaldeletion25MechanismsofimmunologicaltoleranceClonaldeletion:negativeselectionofTcellsinthethymusSelf-Ag:UbiquitousSelf-AgTissue-specificAg(AIRE)26MechanismsofimmunologicaltoleranceClonaldeletion:DeletionofBcellsinthebonemarrow27Mechanismsofimmunologicaltolerance(2)Peripheraltolerance1)ClonaldeletionSomeself-antigensarepresentathighconcentrationintheperipherallymphoidorgans,andTCRbindtheseantigensinhighaffinity,butAPCsexpressfewornocostimulators.28Mechanismsofimmunologicaltolerance(2)Peripheraltolerance2)ImmunologicalignoranceSomeself-antigensarepresentatlowconcentrationintheperipherallymphoidorgans,andTCRbindtheseantigensinlowaffinity,butAPCsexpressfewornocostimulators.29MechanismsofimmunologicaltoleranceNocostimulators3)Clonalanergy(2)Peripheraltolerance30Mechanismsofimmunologicaltolerance(2)Peripheraltolerance4)RegulatoryTcells31Mechanismsofimmunologicaltolerance(2)Peripheraltolerance4)RegulatoryTcells32Mechanismsofimmunologicaltolerance33Mechanismsofimmunologicaltolerance(2)PeripheraltoleranceCharacteristicsnTregiTregInduction

siteThymusPeripheryCD25

expression+++-/+Foxp3++++Ag-specificAuto-Ag(thymus)Tissue-specificAgandforeignAgeffectCell-cellcontact,cytokineproductionCytokine

dependentfunctionInhibition

of

auto-reactive

T

cell

immune

responseInhibitionofauto-reactiveinflammationandgraftrejection,benefitforcancer34Mechanismsofimmunologicaltolerance(2)Peripheraltolerance5)Cytokine35Mechanismsofimmunologicaltolerance(2)Peripheraltolerance6)Signaltransductiondeficiencynegativesignal:PD-1CTLA-4Synthesisinhibited36Mechanismsofimmunologicaltolerance(2)Peripheraltolerance7)ImmunologicallyprivilegedsitesAnatomicbarrierActionofSuppressorlymphocyte(Ts)Actionofcytokines:TGF-β,IL-10ExpressionofFasLapoptosisBrainEyesPlacentaTesticles3738IntroductionEstablishmentofimmunologicaltoleranceMechanismsofimmunologicaltoleranceSignificanceandclinicalapplicationContents

39AutoimmunediseaseOrgantransplantationChronicinfectionTumorInduceBreakupImmunotoleranceSignificance

溫馨提示

  • 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請下載最新的WinRAR軟件解壓。
  • 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
  • 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
  • 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
  • 5. 人人文庫網(wǎng)僅提供信息存儲(chǔ)空間,僅對用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對任何下載內(nèi)容負(fù)責(zé)。
  • 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請與我們聯(lián)系,我們立即糾正。
  • 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對自己和他人造成任何形式的傷害或損失。

評(píng)論

0/150

提交評(píng)論